Mesenchymal stem cell derived extracellular vesicles: promising immunomodulators against autoimmune, autoinflammatory disorders and SARS-CoV-2 infection

Discovery of novel and broad-acting immunomodulators is of critical importance for the prevention and treatment of disorders occurring due to overexuberant immune responseincluding SARS-CoV-2 triggered cytokine storm leading to lung pathology and mortality during the ongoing viral pandemic. Mesenchymal stem/stromal cells (MSCs), highly regarded for their regenerative capacities, also possessesremarkable immunoregulatory functions affecting all types of innate and adaptive immune cells. Owing to that, MSCs have been heavily investigated in clinic for the treatment of autoimmune and inflammatory diseases along with transplant rejection. Extensive research in the last decaderevealed that MSCs carry out most of their functions through paracrine factors which are soluble mediators and extracellular vesicles (EVs). EVs, including exosomes and microvesicles, are an efficient way of intercellular communication due to their unique ability to carry biological messages such as transcription factors, growth factors, cytokines, mRNAs and miRNAs over long distances. EVs originate through direct budding of the cell membrane or the endosomal secretion pathway and they consist of the cytosolic and membrane components of their parent cell. Therefore, they are able to mimic the characteristics of the parent cell, affecting the target cells upon binding or internalization. EVs secreted by MSCs are emerging as a cell-free alternative to MSC-based therapies. MSC EVs are being tested in preclinical and clinical settings where they exhibit exceptional immunosuppressivecapacity. They regulate the migration, proliferation, activation and polarization of various immune cells, promoting a tolerogenic immune response while inhibiting inflammatory response. Being as effective immunomodulators as their parent cells, MSC EVs are also preferable over MSC-based therapies due to their lower risk of immunogenicity, tumorigenicity and overall superior safety. In this review, we present the outcomes of preclinical and clinical studies utilizing MSC EVs as therapeutic agents for the treatment of a wide variety of immunological disorders. (THORLAB), Tıp Fakültesi Bilim,Ankara, Türkiye

PDF

___

Akiyama K, Chen C, Wang D, Xu X, Qu C et al. (2012). Mesenchymalstem-cell-induced immunoregulation involves FAS-ligand-/ FAS-mediated T cell apoptosis. Cell Stem Cell 10 (5): 544-555. doi: 10.1016/j.stem.2012.03.007
Arslan F, Lai RC, Smeets MB, Akeroyd L, Choo A et al. (2013). Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury. Stem Cell Research 10 (3): 301-312. doi: 10.1016/j.scr.2013.01.002
Arthur A, Rychkov G, Shi S, Koblar SA, Gronthos S (2008). Adult human dental pulp stem cells differentiate toward functionally active neurons under appropriate environmental cues. Stem Cells 26 (7): 1787-1795. doi: 10.1634/stemcells.2007-0979
Bai L, Shao H, Wang H, Zhang Z, Su C et al. (2017). Effects of mesenchymal stem cell-derived exosomes on experimental autoimmune uveitis. Scientific Reports 7 (1): 4323. doi: 10.1038/s41598-017-04559-y
Bernardo ME, Fibbe WE (2013). Mesenchymal stromal cells: sensors and switchers of inflammation. Cell Stem Cell 13 (4): 392-402. doi: 10.1016/j.stem.2013.09.006
Bian S, Zhang L, Duan L, Wang X, Min Y et al. (2014). Extracellular vesicles derived from human bone marrow mesenchymal stem cells promote angiogenesis in a rat myocardial infarction model. Journal of Molecular Medicine 92 (4): 387-397. doi: 10.1007/s00109-013-1110-5
Brandau S, Jakob M, Hemeda H, Bruderek K, Janeschik S et al. (2010) Tissue-resident mesenchymal stem cells attract peripheral blood neutrophils and enhance their inflammatory activity in response to microbial challenge. Journal of Leukocyte Biology 88 (5): 1005-10015. doi: 10.1189/jlb.0410207
Brown JM, Nemeth K, Kushnir-Sukhov NM, Metcalfe DD, Mezey E (2011). Bone marrow stromal cells inhibit mast cell function via a COX2-dependent mechanism. Clinical and Experimental Allergy 41 (4): 526-534. doi: 10.1111/j.1365-2222.2010.03685.x
Caplan AI, Dennis JE (2006). Mesenchymal stem cells as trophic mediators. Journal of Cellular Biochemistry 98 (5): 1076-84. doi: 10.1002/jcb.20886
Chatterjee D, Tufa DM, Baehre H, Hass R, Schmidt RE et al. (2014). Natural killer cells acquire CD73 expression upon exposure to mesenchymal stem cells. Blood 123 (4): 594-595. doi: 10.1182/ blood-2013-09-524827
Chen L, Tredget EE, Wu PY, Wu Y (2008). Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PloS One 3 (4): e1886. doi: 10.1371/journal.pone.0001886
Cho DI, Kim MR, Jeong HY, Jeong HC, Jeong MH et al. (2014) Mesenchymal stem cells reciprocally regulate the M1/ M2 balance in mouse bone marrow-derived macrophages. Experimental & Molecular Medicine 46 (1): e70. doi: 10.1038/ emm.2013.135
Choi H, Lee RH, Bazhanov N, Oh JY, Prockop DJ (2011). Antiinflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-kappaB signaling in resident macrophages. Blood 118 (2): 330-338. doi: 10.1182/blood-2010-12-327353
Ciccocioppo R, Bernardo ME, Sgarella A, Maccario R, Avanzini MA et al. (2011). Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn’s disease. Gut 60 (6): 788-798. doi: 10.1136/gut.2010.214841
Corcione A, Benvenuto F, Ferretti E, Giunti D, Cappiello V et al. (2006). Human mesenchymal stem cells modulate B-cell functions. Blood 107 (1): 367-372. doi: 10.1182/ blood-2005-07-2657
Cosenza S, Toupet K, Maumus M, Luz-Crawford P, Blanc-Brude O et al. (2018). Mesenchymal stem cells-derived exosomes are more immunosuppressive than microparticles in inflammatory arthritis. Theranostics 8 (5): 1399-1410. doi: 10.7150/ thno.21072.
Cronstein BN (1994). Adenosine, an endogenous anti-inflammatory agent. Journal of Applied Physiology 76 (1): 5-13. doi: 10.1152/ jappl.1994.76.1.5
Crop MJ, Baan CC, Korevaar SS, Ijzermans JN, Pescatori M et al. (2010). Inflammatory conditions affect gene expression and function of human adipose tissue-derived mesenchymal stem cells. Clinical and Experimental Immunology 162 (3): 474-486. doi: 10.1111/j.1365-2249.2010.04256.x
Deng Y, Yi S, Wang G, Cheng J, Zhang Y et al. (2014). Umbilical cord-derived mesenchymal stem cells instruct dendritic cells to acquire tolerogenic phenotypes through the IL-6-mediated upregulation of SOCS1. Stem Cells and Development 23 (17): 2080-2092. doi: 10.1089/scd.2013.0559
Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD et al. (2002). Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99 (10): 3838-3843. doi: 10.1182/ blood.v99.10.3838
Ding DC, Shyu WC, Lin SZ (2011). Mesenchymal stem cells. Cell Transplantation 20 (1): 5-14. doi: 10.3727/096368910X
Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F et al. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8 (4): 315- 317. doi: 10.1080/14653240600855905
El Omar R, Beroud J, Stoltz JF, Menu P, Velot E et al. (2014). Umbilical cord mesenchymal stem cells: the new gold standard for mesenchymal stem cell-based therapies? Tissue Engineering Part B, Reviews 20 (5): 523-544. doi: 10.1089/ten. TEB.2013.0664
Figliuzzi M, Bonandrini B, Silvani S, Remuzzi A (2014). Mesenchymal stem cells help pancreatic islet transplantation to control type 1 diabetes. World Journal of Stem Cells 6 (2): 163-172. doi: 10.4252/wjsc.v6.i2.163
Forbes GM, Sturm MJ, Leong RW, Sparrow MP, Segarajasingam D et al. (2014). A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn’s disease refractory to biologic therapy. Clinical Gastroenterology and Hepatology 12 (1): 64-71. doi: 10.1016/j.cgh.2013.06.021
Franquesa M, Mensah FK, Huizinga R, Strini T, Boon L et al. (2015) Human adipose tissue-derived mesenchymal stem cells abrogate plasmablast formation and induce regulatory B cells independently of T helper cells. Stem Cells 33 (3): 880-891. doi: 10.1002/stem.1881
Friedenstein AJ, Chailakhjan RK, Lalykina KS (1970). The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell and Tissue Kinetics 3 (4): 393-403.
Glennie S, Soeiro I, Dyson PJ, Lam EW, Dazzi F (2005). Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 105 (7): 2821-2827. doi: 10.1182/ blood-2004-09-3696
Hass R, Kasper C, Bohm S, Jacobs R (2011). Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC. Cell Communication and Signaling 9 (1): 12. doi: 10.1186/1478- 811X-9-12
Hoffmann M, Kleine-Weber H, Krüger N, Mueller MA, Drosten C et al. (2020). The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells. BioRxiv. doi: 10.1101/2020.01.31.929042
Jiang D, Muschhammer J, Qi Y, Kugler A, de Vries JC et al. (2016) Suppression of neutrophil-mediated tissue damage-a novel skill of mesenchymal stem cells. Stem Cells 34 (9): 2393-2406. doi: 10.1002/stem.2417
Kalinski P (2012). Regulation of immune responses by prostaglandin E2. Journal of Immunology 188 (1): 21-28. doi: 10.4049/ jimmunol.1101029
Karussis D, Karageorgiou C, Vaknin-Dembinsky A, GowdaKurkalli B, Gomori JM et al. (2010). Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Archives of Neurology 67 (10): 1187-1194. doi: 10.1001/ archneurol.2010.248
Kim HS, Lee JH, Roh KH, Jun HJ, Kang KS et al. (2017). Clinical trial of human umbilical cord blood-derived stem cells for the treatment of moderate-to-severe atopic dermatitis: phase I/IIa studies. Stem Cells 35 (1): 248-255. doi: 10.1002/stem.2401
Kim HS, Yun JW, Shin TH, Lee SH, Lee BC et al. (2015) Human umbilical cord blood mesenchymal stem cell-derived PGE2 and TGF-beta1 alleviate atopic dermatitis by reducing mast cell degranulation. Stem Cells 33 (4): 1254-1266. doi: 10.1002/ stem.1913
Kordelas L, Rebmann V, Ludwig AK, Radtke S, Ruesing J et al. (2014). MSC-derived exosomes: a novel tool to treat therapyrefractory graft-versus-host disease. Leukemia 28 (4): 970-973. doi: 10.1038/leu.2014.41
Lai RC, Arslan F, Lee MM, Sze NS, Choo A et al. (2010). Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Research 4 (3): 214-222. doi: 10.1016/j. scr.2009.12.003
Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H et al. (2008). Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 371 (9624): 1579-1586. doi: 10.1016/S0140-6736(08)60690-X
Lee C, Mitsialis SA, Aslam M, Vitali SH, Vergadi E et al. (2012). Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension.Circulation 126 (22): 2601-2611. doi: 10.1161/ CIRCULATIONAHA.112.114173
Leng Z, Zhu R, Hou W, Feng Y, Yang Y et al. (2020). Transplantation of ACE2-mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia. Aging and Disease 11 (2): 216-228. doi: 10.14336/AD.2020.0228
Li T, Yan Y, Wang B, Qian H, Zhang X et al. (2013). Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis. Stem Cells and Development 22 (6): 845-854. doi: 10.1089/scd.2012.0395
Li X, Bai J, Ji X, Li R, Xuan Y et al. (2014). Comprehensive characterization of four different populations of human mesenchymal stem cells as regards their immune properties, proliferation and differentiation. International Journal of Molecular Medicine 34 (3): 695-704. doi: 10.3892/ ijmm.2014.1821
Liu W, Zhang Q, Chen J, Xiang R, Song H et al. (2020). Detection of covid-19 in children in early January 2020 in Wuhan, China. New England Journal of Medicine 382 (14): 1370-1371. doi: 10.1056/NEJMc2003717
Liu X, Qu X, Chen Y, Liao L, Cheng K et al. (2012) Mesenchymal stem/stromal cells induce the generation of novel IL-10- dependent regulatory dendritic cells by SOCS3 activation. Journal of Immunology 189 (3): 1182-1192. doi: 10.4049/ jimmunol.1102996
Luz-Crawford P, Djouad F, Toupet K, Bony C, Franquesa M et al. (2016). Mesenchymal stem cell-derived interleukin 1 receptor antagonist promotes macrophage polarization and inhibits B cell differentiation. Stem Cells 34 (2): 483-492. doi: 10.1002/ stem.2254
Luz-Crawford P, Kurte M, Bravo-Alegria J, Contreras R, NovaLamperti E et al. (2013). Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells. Stem Cell Research & Therapy 4 (3): 65. doi: 10.1186/scrt216
Maas SLN, Breakefield XO, Weaver AM (2017). Extracellular vesicles: unique intercellular delivery vehicles. Trends in Cell Biology 27 (3): 172-188. doi: 10.1016/j.tcb.2016.11.003
Mao F, Wu Y, Tang X, Kang J, Zhang B et al. (2017). Exosomes derived from human umbilical cord mesenchymal stem cells relieve inflammatory bowel disease in mice. BioMed Research International 2017: 5356760. doi: 10.1155/2017/5356760
Marrazzo P, Crupi AN, Alviano F, Teodori L, Bonsi L. (2019). Exploring the roles of MSCs in infections: focus on bacterial diseases. Journal of Molecular Medicine 97 (4): 437-450. doi: 10.1007/s00109-019-01752-6
Melief SM, Zwaginga JJ, Fibbe WE, Roelofs H (2013). Adipose tissue-derived multipotent stromal cells have a higher immunomodulatory capacity than their bone marrow-derived counterparts. Stem Cells Translational Medicine 2(6): 455-463. doi: 10.5966/sctm.2012-0184
Minciacchi VR, Freeman MR, Di Vizio D (2015). Extracellular vesicles in cancer: exosomes, microvesicles and the emerging role of large oncosomes. Seminars in Cell & Developmental Biology 40: 41-51. doi: 10.1016/j.semcdb.2015.02.010
Nassar W, El-Ansary M, Sabry D, Mostafa MA, Fayad T et al. (2016). Umbilical cord mesenchymal stem cells derived extracellular vesicles can safely ameliorate the progression of chronic kidney diseases. Biomaterials Research 20: 21. doi: 10.1186/s40824- 016-0068-0
Nemeth K, Leelahavanichkul A, Yuen PS, Mayer B, Parmelee A et al. (2009). Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nature Medicine 15 (1): 42-49. doi: 10.1038/nm.1905
Nojehdehi S, Soudi S, Hesampour A, Rasouli S, Soleimani M et al. (2018). Immunomodulatory effects of mesenchymal stem cell-derived exosomes on experimental type-1 autoimmune diabetes. Journal of Cellular Biochemistry 119 (11): 9433-9443.
Pan GH, Chen Z, Xu L, Zhu JH, Xiang P et al. (2016). Low-dose tacrolimus combined with donor-derived mesenchymal stem cells after renal transplantation: a prospective, nonrandomized study. Oncotarget 7 (11): 12089-12101. doi: 10.18632/oncotarget.7725
Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R et al. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284 (5411):143-147. doi: 10.1126/ science.284.5411.143
Plumas J, Chaperot L, Richard MJ, Molens JP, Bensa JC et al. (2005). Mesenchymal stem cells induce apoptosis of activated T cells. Leukemia 19 (9): 1597-1604. doi: 10.1038/sj.leu.2403871
Ren G, Zhang L, Zhao X, Xu G, Zhang Y et al. (2008). Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2 (2): 141-150. doi: 10.1016/j.stem.2007.11.014
Schena F, Gambini C, Gregorio A, Mosconi M, Reverberi D et al. (2010). Interferon-gamma-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus. Arthritis and Rheumatism 62 (9): 2776-2786. doi: 10.1002/art.27560
Selleri S, Bifsha P, Civini S, Pacelli C, Dieng MM et al. (2016). Human mesenchymal stromal cell-secreted lactate induces M2-macrophage differentiation by metabolic reprogramming. Oncotarget 7 (21): 30193-30210. doi: 10.18632/oncotarget.8623
Shen B, Liu J, Zhang F, Wang Y, Qin Y et al. (2016). CCR2 positive exosome released by mesenchymal stem cells suppresses macrophage functions and alleviates ischemia/reperfusioninduced renal injury. Stem Cells International 2016: 1240301. doi: 10.1155/2016/1240301
Shigemoto-Kuroda T, Oh JY, Kim DK, Jeong HJ, Park SY et al. (2017). MSC-derived extracellular vesicles attenuate immune responses in two autoimmune murine models: type 1 diabetes and uveoretinitis. Stem Cell Reports 8 (5): 1214-1225. doi: 10.1016/j.stemcr.2017.04.008
Snykers S, De Kock J, Rogiers V, Vanhaecke T (2009). In vitro differentiation of embryonic and adult stem cells into hepatocytes: state of the art. Stem Cells 27 (3): 577-605. doi: 10.1634/stemcells.2008-0963
Spaggiari GM, Capobianco A, Abdelrazik H, Becchetti F, Mingari MC et al. (2008). Mesenchymal stem cells inhibit natural killercell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. Blood 111 (3): 1327-1333. doi: 10.1182/blood-2007-02-074997
Spaggiari GM, Abdelrazik H, Becchetti F, Moretta L (2009). MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2. Blood 113 (26): 6576-6583. doi: 10.1182/blood-2009-02-203943
Stahl PD, Raposo G (2019). Extracellular vesicles: exosomes and microvesicles, integrators of homeostasis. Physiology 34 (3): 169-1677. doi: 10.1152/physiol.00045.2018
Su J, Chen X, Huang Y, Li W, Li J et al. (2014). Phylogenetic distinction of iNOS and IDO function in mesenchymal stem cell-mediated immunosuppression in mammalian species. Cell Death and Differentiation 21 (3): 388-396. doi: 10.1038/ cdd.2013.149
Sun G, Li G, Li D, Huang W, Zhang R et al. (2018). hucMSC derived exosomes promote functional recovery in spinal cord injury mice via attenuating inflammation. Materials Science & Engineering C 89: 194-204. doi: 10.1016/j.msec.2018.04.006
Tabera S, Perez-Simon JA, Diez-Campelo M, Sanchez-Abarca LI, Blanco B et al. (2008). The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes. Haematologica 93 (9): 1301-1309. doi: 10.3324/haematol.12857
Tamura R, Uemoto S, Tabata Y (2016). Immunosuppressive effect of mesenchymal stem cell-derived exosomes on a concanavalin A-induced liver injury model. Inflammation and Regeneration 36: 26. doi: 10.1186/s41232-016-0030-5
Tan J, Wu W, Xu X, Liao L, Zheng F et al. (2012) Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial. Jama 307 (11): 1169-1177. doi: 10.1001/jama.2012.316
Teng X, Chen L, Chen W, Yang J, Yang Z et al. (2015). Mesenchymal stem cell-derived exosomes improve the microenvironment of infarcted myocardium contributing to angiogenesis and antiinflammation. Cellular Physiology and Biochemistry 37 (6): 2415-2424. doi: 10.1159/000438594
Terness P, Bauer TM, Rose L, Dufter C, Watzlik A et al. (2002). Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. The Journal of Experimental Medicine 196 (4): 447-457. doi: 10.1084/ jem.20020052
Wang B, Jia H, Zhang B, Wang J, Ji C et al. (2017). Pre-incubation with hucMSC-exosomes prevents cisplatin-induced nephrotoxicity by activating autophagy. Stem Cell Research & Therapy 8 (1): 75. doi: 10.1186/s13287-016-0463-4
Wang D, Zhang H, Liang J, Li X, Feng X et al. (2013). Allogeneic mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus: 4 years of experience. Cell Transplantation 22 (12): 2267-2277. doi: 10.3727/096368911X582769c
Wang L, Gu Z, Zhao X, Yang N, Wang F et al. (2016). Extracellular vesicles released from human umbilical cord-derived mesenchymal stromal cells prevent life-threatening acute graft-versus-host disease in a mouse model of allogeneic hematopoietic stem cell transplantation. Stem Cells and Development 25 (24): 1874-1883. doi: 10.1089/scd.2016.0107
Waterman RS, Tomchuck SL, Henkle SL, Betancourt AM (2010). A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype. PloS One 5 (4): e10088. doi: 10.1371/ journal.pone.0010088
Wiklander OPB, Brennan MA, Lotvall J, Breakefield XO, El Andaloussi S (2019). Advances in therapeutic applications of extracellular vesicles. Science Translational Medicine 11 (492). doi: 10.1126/scitranslmed.aav8521
Willis GR, Fernandez-Gonzalez A, Anastas J, Vitali SH, Liu X et al. (2018). Mesenchymal stromal cell exosomes ameliorate experimental bronchopulmonary dysplasia and restore lung function through macrophage immunomodulation. American Journal of Respiratory and Critical Care Medicine 197 (1): 104- 116. doi: 10.1164/rccm.201705-0925OC
Yanez-Mo M, Siljander PR, Andreu Z, Zavec AB, Borras FE et al. (2015). Biological properties of extracellular vesicles and their physiological functions. Journal of Extracellular Vesicles 4 (1): 27066. doi: 10.3402/jev.v4.27066
Yang J, Liu XX, Fan H, Tang Q, Shou ZX et al. (2015). Extracellular vesicles derived from bone marrow mesenchymal stem cells protect against experimental colitis via attenuating colon inflammation, oxidative stress and apoptosis. PloS One 10 (10): e0140551. doi: 10.1371/journal.pone.0140551
Yuana Y, Sturk A, Nieuwland R (2013). Extracellular vesicles in physiological and pathological conditions. Blood Reviews 27 (1): 31-39. doi: 10.1016/j.blre.2012.12.002
Zhang B, Liu R, Shi D, Liu X, Chen Y et al. (2009). Mesenchymal stem cells induce mature dendritic cells into a novel Jagged-2- dependent regulatory dendritic cell population. Blood 113 (1): 46-57. doi: 10.1182/blood-2008-04-154138
Zhang QZ, Su WR, Shi SH, Wilder-Smith P, Xiang AP et al. (2010) Human gingiva-derived mesenchymal stem cells elicit polarization of m2 macrophages and enhance cutaneous wound healing. Stem Cells 28 (10): 1856-1868. doi: 10.1002/ stem.503
Zhang W, Ge W, Li C, You S, Liao L et al. (2004). Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells. Stem Cells and Development 13 (3): 263-271. doi: 10.1089/154732804323099190
Zhang Z, Yang J, Yan W, Li Y, Shen Z et al. (2016). Pretreatment of cardiac stem cells with exosomes derived from mesenchymal stem cells enhances myocardial repair. Journal of the American Heart Association 5 (1): e002856. doi: 10.1161/ JAHA.115.002856
Zhao H, Shang Q, Pan Z, Bai Y, Li Z et al. (2018). Exosomes from adipose-derived stem cells attenuate adipose inflammation and obesity through polarizing M2 macrophages and beiging in white adipose tissue. Diabetes 67 (2): 235-247. doi: 10.2337/ db17-0356
Zhao K, Lou R, Huang F, Peng Y, Jiang Z et al. (2015). Immunomodulation effects of mesenchymal stromal cells on acute graft-versus-host disease after hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation 21 (1): 97-104. doi: 10.1016/j.bbmt.2014.09.030
Zhao RC. (2020). Stem cell-based therapy for coronavirus disease 2019. Stem Cells and Development. doi: 10.1089/scd.2020.0071